Applied Therapeutics, Inc. (APLT)

Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	98.87	49.9	16.66	53.89	57.47	18.85
Short-Term Investments	-	-	13.92	26.94	39.36	20
Cash & Short-Term Investments	98.87	49.9	30.58	80.82	96.83	38.85
Cash Growth	163.95%	63.17%	-62.16%	-16.53%	149.21%	107.24%
Other Receivables	0.26	0.29	0.28	0.53	0.51	-
Receivables	0.26	0.29	0.28	0.53	0.51	-
Prepaid Expenses	2.34	1.07	2.12	2.56	2.91	1.43
Other Current Assets	3.14	3.13	4.33	4.48	2.35	5.87
Total Current Assets	104.6	54.39	37.31	88.39	102.59	46.16
Property, Plant & Equipment	1.96	0.45	0.86	1.3	1.71	2.04
Other Long-Term Assets	-	-	0.2	0.2	0.2	0.2
Total Assets	106.57	54.83	38.36	89.89	104.51	48.39
Accounts Payable	2.84	1.74	4.53	9.46	0.64	8.79
Accrued Expenses	12.72	13.93	13.65	14.78	18.56	4.69
Short-Term Debt	-	0.31	0.62	0.79	1.07	-
Current Portion of Leases	0.26	0.43	0.48	0.44	0.41	0.36
Current Unearned Revenue	0.21	0.67	-	-	-	-
Other Current Liabilities	82.94	54.1	14.14	0.99	0.55	0.26
Total Current Liabilities	98.97	71.18	33.42	26.46	21.24	14.1
Long-Term Leases	1.71	0.04	0.41	0.89	1.33	1.68
Other Long-Term Liabilities	-	0.76	0.46	-	-	-
Total Liabilities	100.67	71.98	34.3	27.35	22.57	15.78
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	624.1	451.43	352.83	328.96	242.78	99.38
Retained Earnings	-618.22	-468.59	-348.82	-266.32	-160.73	-66.77
Comprehensive Income & Other	-	-	0.05	-0.11	-0.11	-0
Total Common Equity	5.89	-17.15	4.06	62.54	81.94	32.61
Shareholders' Equity	5.89	-17.15	4.06	62.54	81.94	32.61
Total Liabilities & Equity	106.57	54.83	38.36	89.89	104.51	48.39
Total Debt	1.97	0.78	1.51	2.12	2.81	2.04
Net Cash (Debt)	96.9	49.12	29.07	78.7	94.02	36.82
Net Cash Growth	168.06%	68.99%	-63.07%	-16.29%	155.38%	96.37%
Net Cash Per Share	0.74	0.58	0.77	3.07	4.28	2.87
Filing Date Shares Outstanding	116.36	105.89	48.11	26.22	26.01	21.97
Total Common Shares Outstanding	116.36	84.87	48.06	26.22	22.49	18.53
Working Capital	5.64	-16.8	3.88	61.93	81.36	32.06
Book Value Per Share	0.05	-0.20	0.08	2.39	3.64	1.76
Tangible Book Value	5.89	-17.15	4.06	62.54	81.94	32.61
Tangible Book Value Per Share	0.05	-0.20	0.08	2.39	3.64	1.76

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q